Your browser doesn't support javascript.
loading
In Situ Maturation and Tissue Adaptation of Type 2 Innate Lymphoid Cell Progenitors.
Zeis, Patrice; Lian, Mi; Fan, Xiying; Herman, Josip S; Hernandez, Daniela C; Gentek, Rebecca; Elias, Shlomo; Symowski, Cornelia; Knöpper, Konrad; Peltokangas, Nina; Friedrich, Christin; Doucet-Ladeveze, Remi; Kabat, Agnieszka M; Locksley, Richard M; Voehringer, David; Bajenoff, Marc; Rudensky, Alexander Y; Romagnani, Chiara; Grün, Dominic; Gasteiger, Georg.
Afiliação
  • Zeis P; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; International Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB), Freiburg, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany.
  • Lian M; Würzburg Institute of Systems Immunology, Max Planck Research Group at the Julius-Maximilians-Universität Würzburg, Würzburg, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany; Institute of Medical Microbiology and Hygiene, University Medical Center Freiburg, Freiburg, Germany.
  • Fan X; Howard Hughes Medical Institute, Immunology Program, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Herman JS; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; International Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB), Freiburg, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany.
  • Hernandez DC; German Rheumatism Research Center (DRFZ), Leibniz Association, Berlin, Germany; Medical Department I, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Gentek R; Aix Marseille Université, CNRS, INSERM, CIML, Marseille, France.
  • Elias S; Howard Hughes Medical Institute, Immunology Program, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Symowski C; Department of Infection Biology, University Hospital Erlangen and Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
  • Knöpper K; Würzburg Institute of Systems Immunology, Max Planck Research Group at the Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
  • Peltokangas N; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany.
  • Friedrich C; Würzburg Institute of Systems Immunology, Max Planck Research Group at the Julius-Maximilians-Universität Würzburg, Würzburg, Germany; Institute of Medical Microbiology and Hygiene, University Medical Center Freiburg, Freiburg, Germany.
  • Doucet-Ladeveze R; Würzburg Institute of Systems Immunology, Max Planck Research Group at the Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
  • Kabat AM; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Locksley RM; Howard Hughes Medical Institute and Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Voehringer D; Department of Infection Biology, University Hospital Erlangen and Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
  • Bajenoff M; Aix Marseille Université, CNRS, INSERM, CIML, Marseille, France.
  • Rudensky AY; Howard Hughes Medical Institute, Immunology Program, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Romagnani C; German Rheumatism Research Center (DRFZ), Leibniz Association, Berlin, Germany; Medical Department I, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Grün D; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; CIBSS-Centre for Integrative Biological Signaling Studies, University of Freiburg, Freiburg, Germany. Electronic address: gruen@ie-freiburg.mpg.de.
  • Gasteiger G; Würzburg Institute of Systems Immunology, Max Planck Research Group at the Julius-Maximilians-Universität Würzburg, Würzburg, Germany; Institute of Medical Microbiology and Hygiene, University Medical Center Freiburg, Freiburg, Germany. Electronic address: georg.gasteiger@uni-wuerzburg.de.
Immunity ; 53(4): 775-792.e9, 2020 10 13.
Article em En | MEDLINE | ID: mdl-33002412
ABSTRACT
Innate lymphoid cells (ILCs) are generated early during ontogeny and persist predominantly as tissue-resident cells. Here, we examined how ILCs are maintained and renewed within tissues. We generated a single cell atlas of lung ILC2s and found that Il18r1+ ILCs comprise circulating and tissue-resident ILC progenitors (ILCP) and effector-cells with heterogeneous expression of the transcription factors Tcf7 and Zbtb16, and CD103. Our analyses revealed a continuous differentiation trajectory from Il18r1+ ST2- ILCPs to Il18r- ST2+ ILC2s, which was experimentally validated. Upon helminth infection, recruited and BM-derived cells generated the entire spectrum of ILC2s in parabiotic and shield chimeric mice, consistent with their potential role in the renewal of tissue ILC2s. Our findings identify local ILCPs and reveal ILCP in situ differentiation and tissue adaptation as a mechanism of ILC maintenance and phenotypic diversification. Local niches, rather than progenitor origin, or the developmental window during ontogeny, may dominantly imprint ILC phenotypes in adult tissues.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tratamento Base de dados: MEDLINE Assunto principal: Linfócitos / Células Progenitoras Linfoides / Imunidade Inata Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Immunity Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tratamento Base de dados: MEDLINE Assunto principal: Linfócitos / Células Progenitoras Linfoides / Imunidade Inata Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Immunity Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha